ARCUTIS BIOTHERAPEUTICS INC (ARQT) Institutional Ownership Changes & 13F Activity
ARCUTIS BIOTHERAPEUTICS INC (ARQT). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Gilder Gagnon Howe & Co Llc, Orbimed Advisors Llc, D. E. Shaw & Co., Inc., Driehaus Capital Management Llc, and Citadel Advisors Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Buy | +307,896 | +61.1% | 811,752 | $21.28M | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Buy | +1,144,408 | +7333.1% | 1,160,014 | $30.42M | Q2 2026 | Sep 02, 2026 |
| California State Teachers Retirement System | Sell | -2,059 | -1.6% | 126,258 | $3.31M | Q2 2026 | Aug 24, 2026 |
| Gilder Gagnon Howe & Co Llc | Sell | -2,990,799 | -69.5% | 1,313,211 | $34.43M | Q2 2026 | Aug 14, 2026 |
| Orbimed Advisors Llc | Buy | +2,042,000 | — | 2,042,000 | $53.54M | Q2 2026 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +1,453,387 | +58.2% | 3,949,609 | $103.56M | Q2 2026 | Aug 14, 2026 |
| Driehaus Capital Management Llc | Sell | -1,347,603 | -60.5% | 878,426 | $23.03M | Q2 2026 | Aug 14, 2026 |
| Polar Capital Holdings Plc | Buy | +940,005 | +16.6% | 6,606,945 | $173.23M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +766,142 | +34.5% | 2,987,431 | $78.33M | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Sell | -565,743 | -51.3% | 537,747 | $14.10M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Buy | +514,739 | +1043.4% | 564,072 | $14.79M | Q2 2026 | Aug 14, 2026 |
| Eversept Partners, Lp | Sell | -441,225 | -76.5% | 135,355 | $3.55M | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +429,570 | +183.3% | 663,877 | $17.41M | Q2 2026 | Aug 14, 2026 |
| Voloridge Investment Management, Llc | Sell | -383,082 | -70.9% | 157,429 | $4.13M | Q2 2026 | Aug 14, 2026 |
| Qube Research & Technologies Ltd | Sell | -362,405 | -50.1% | 361,662 | $9.48M | Q2 2026 | Aug 14, 2026 |
| Longaeva Partners L.P. | Buy | +344,796 | — | 344,796 | $9.04M | Q2 2026 | Aug 14, 2026 |
| Stempoint Capital Lp | Sell | -314,847 | -76.1% | 98,945 | $2.59M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +295,997 | — | 295,997 | $7.76M | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Sell | -290,429 | -64.8% | 157,778 | $4.14M | Q2 2026 | Aug 14, 2026 |
| Cormorant Asset Management, Lp | Sell | -275,000 | -61.1% | 175,000 | $4.59M | Q2 2026 | Aug 14, 2026 |
| Ensign Peak Advisors, Inc | Sell | -269,853 | -21.7% | 974,534 | $25.55M | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +264,907 | — | 264,907 | $6.95M | Q2 2026 | Aug 14, 2026 |
| Balyasny Asset Management L.P. | Buy | +243,119 | — | 243,119 | $6.37M | Q2 2026 | Aug 14, 2026 |
| Pfm Health Sciences, Lp | Buy | +242,069 | — | 242,069 | $6.35M | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Sell | -234,037 | -82.5% | 49,586 | $1.30M | Q2 2026 | Aug 14, 2026 |
| Point72 Asset Management, L.P. | Sell | -228,428 | -38.7% | 362,449 | $9.50M | Q2 2026 | Aug 14, 2026 |
| Bamco Inc | Buy | +180,931 | +16.9% | 1,253,120 | $32.86M | Q2 2026 | Aug 14, 2026 |
| Holocene Advisors, Lp | Buy | +163,732 | — | 163,732 | $4.29M | Q2 2026 | Aug 14, 2026 |
| Castleark Management Llc | Sell | -156,040 | -53.2% | 137,420 | $3.60M | Q2 2026 | Aug 14, 2026 |
| Aqr Capital Management Llc | Sell | -137,929 | -29.5% | 330,324 | $8.66M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about ARQT activity
Which institutional owners are buying ARQT?
Institutional owners buying ARQT include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in ARQT activity?
"Buy" means an investor increased their reported position in ARQT compared to the prior reporting period. This reflects growing exposure to ARCUTIS BIOTHERAPEUTICS INC (ARQT) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in ARQT increasing?
Institutional interest in ARQT can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related ARQT Institutional Insights
- ARQT Overview
- ARQT 13F Institutional Holders
- ARQT Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ARQT Insider Trading & SEC Form 4 Activity
- ARQT Articles
- Top Institutional Investor Stock Rankings